Annual SGA
$11.65 M
-$3.36 M-22.39%
December 31, 2023
Summary
- As of February 12, 2025, NVNO annual SGA is $11.65 million, with the most recent change of -$3.36 million (-22.39%) on December 31, 2023.
- During the last 3 years, NVNO annual SGA has risen by +$6.77 million (+138.69%).
- NVNO annual SGA is now -22.39% below its all-time high of $15.02 million, reached on December 31, 2022.
Performance
NVNO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.31 M
+$682.00 K+25.94%
September 30, 2024
Summary
- As of February 12, 2025, NVNO quarterly SGA is $3.31 million, with the most recent change of +$682.00 thousand (+25.94%) on September 30, 2024.
- Over the past year, NVNO quarterly SGA has increased by +$14.00 thousand (+0.42%).
- NVNO quarterly SGA is now -54.08% below its all-time high of $7.21 million, reached on December 31, 2021.
Performance
NVNO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$550.67 M
-$21.24 M-4.01%
September 30, 2024
Summary
- As of February 12, 2025, NVNO TTM SGA is -$550.67 million, with the most recent change of -$21.24 million (-4.01%) on September 30, 2024.
- Over the past year, NVNO TTM SGA has dropped by -$562.32 million (-4826.82%).
- NVNO TTM SGA is now -1885.96% below its all-time high of -$27.73 million.
Performance
NVNO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NVNO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.4% | +0.4% | -4826.8% |
| 3 y3 years | +138.7% | +3.4% | -3914.3% |
| 5 y5 years | +79.8% | +3.4% | -3914.3% |
NVNO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.4% | +4.4% | -54.1% | +35.1% | -87.8% | at low |
| 5 y | 5-year | -22.4% | +138.7% | -54.1% | +294.3% | -159.4% | at low |
| alltime | all time | -22.4% | +803.6% | -54.1% | +294.3% | -1886.0% | at low |
EnVVeno Medical Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.31 M(+25.9%) | $11.69 M(+7.0%) |
| Jun 2024 | - | $2.63 M(+7.3%) | $10.93 M(+0.3%) |
| Mar 2024 | - | $2.45 M(-25.7%) | $10.90 M(-6.4%) |
| Dec 2023 | $11.65 M(-22.4%) | $3.30 M(+29.2%) | $11.65 M(-3.0%) |
| Sep 2023 | - | $2.55 M(-1.9%) | $12.02 M(-8.4%) |
| Jun 2023 | - | $2.60 M(-18.8%) | $13.12 M(-9.1%) |
| Mar 2023 | - | $3.20 M(-12.6%) | $14.44 M(-3.9%) |
| Dec 2022 | $15.02 M(+34.5%) | $3.66 M(+0.1%) | $15.02 M(-19.1%) |
| Sep 2022 | - | $3.66 M(-6.5%) | $18.57 M(+13.3%) |
| Jun 2022 | - | $3.91 M(+3.4%) | $16.39 M(+19.0%) |
| Mar 2022 | - | $3.78 M(-47.5%) | $13.77 M(+23.3%) |
| Dec 2021 | $11.16 M(+128.7%) | $7.21 M(+386.6%) | $11.16 M(+91.3%) |
| Sep 2021 | - | $1.48 M(+14.4%) | $5.84 M(+5.8%) |
| Jun 2021 | - | $1.30 M(+10.2%) | $5.52 M(+9.0%) |
| Mar 2021 | - | $1.18 M(-37.5%) | $5.06 M(+3.6%) |
| Dec 2020 | $4.88 M | $1.88 M(+61.6%) | $4.88 M(+24.4%) |
| Sep 2020 | - | $1.16 M(+38.6%) | $3.92 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $839.70 K(-15.9%) | $3.92 M(-15.0%) |
| Mar 2020 | - | $997.90 K(+8.2%) | $4.61 M(-6.2%) |
| Dec 2019 | $4.91 M(-24.2%) | $922.30 K(-20.3%) | $4.91 M(-5.7%) |
| Sep 2019 | - | $1.16 M(-24.5%) | $5.21 M(+1.0%) |
| Jun 2019 | - | $1.53 M(+17.8%) | $5.15 M(-21.2%) |
| Mar 2019 | - | $1.30 M(+6.9%) | $6.54 M(+0.8%) |
| Dec 2018 | $6.48 M(+18.8%) | $1.22 M(+10.1%) | $6.48 M(-6.4%) |
| Sep 2018 | - | $1.10 M(-62.1%) | $6.92 M(-7.5%) |
| Jun 2018 | - | $2.91 M(+133.7%) | $7.48 M(+32.4%) |
| Mar 2018 | - | $1.25 M(-24.7%) | $5.65 M(+3.6%) |
| Dec 2017 | $5.46 M(+17.7%) | $1.66 M(-0.4%) | $5.46 M(+8.5%) |
| Sep 2017 | - | $1.66 M(+53.3%) | $5.03 M(+16.3%) |
| Jun 2017 | - | $1.09 M(+3.4%) | $4.32 M(+33.5%) |
| Mar 2017 | - | $1.05 M(-14.6%) | $3.24 M(+48.0%) |
| Dec 2016 | $4.63 M(+259.3%) | $1.23 M(+28.1%) | $2.19 M(+128.1%) |
| Sep 2016 | - | $958.80 K | $958.80 K |
| Dec 2015 | $1.29 M | - | - |
FAQ
- What is enVVeno Medical annual SGA?
- What is the all time high annual SGA for enVVeno Medical?
- What is enVVeno Medical annual SGA year-on-year change?
- What is enVVeno Medical quarterly SGA?
- What is the all time high quarterly SGA for enVVeno Medical?
- What is enVVeno Medical quarterly SGA year-on-year change?
- What is enVVeno Medical TTM SGA?
- What is the all time high TTM SGA for enVVeno Medical?
- What is enVVeno Medical TTM SGA year-on-year change?
What is enVVeno Medical annual SGA?
The current annual SGA of NVNO is $11.65 M
What is the all time high annual SGA for enVVeno Medical?
enVVeno Medical all-time high annual SGA is $15.02 M
What is enVVeno Medical annual SGA year-on-year change?
Over the past year, NVNO annual SGA has changed by -$3.36 M (-22.39%)
What is enVVeno Medical quarterly SGA?
The current quarterly SGA of NVNO is $3.31 M
What is the all time high quarterly SGA for enVVeno Medical?
enVVeno Medical all-time high quarterly SGA is $7.21 M
What is enVVeno Medical quarterly SGA year-on-year change?
Over the past year, NVNO quarterly SGA has changed by +$14.00 K (+0.42%)
What is enVVeno Medical TTM SGA?
The current TTM SGA of NVNO is -$550.67 M
What is the all time high TTM SGA for enVVeno Medical?
enVVeno Medical all-time high TTM SGA is -$27.73 M
What is enVVeno Medical TTM SGA year-on-year change?
Over the past year, NVNO TTM SGA has changed by -$562.32 M (-4826.82%)